Mokemei Zhengzhou Biotechnology MKM
Mokemei Zhengzhou Biotechnology MKM's evidence is concentrated in Retatrutide, where recent testing shows strong identity and purity. The record is narrow rather than catalog-wide, with thin batch traceability and a dispersed fill history from underfilled early lots to later overfills.
Chinese registry, WHOIS, and export records conflict with MKM's long-history narrative, including a non-peptide cargo trail. The report also maps same-server peptide infrastructure, forum review control, shipping disputes, and a reported HYNH Telegram channel.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Mokemei Zhengzhou Biotechnology MKM rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 23 Jul 2026 | Fail | GHK-Cu Mokemei Zhengzhou Biotechnology MKM | lab name | View COA | |||
| 20 Jul 2026 | Pass | Retatrutide Mokemei Zhengzhou Biotechnology MKM | lab name | View COA | |||
| 17 Jul 2026 | Fail | Retatrutide Mokemei Zhengzhou Biotechnology MKM | lab name | View COA | |||
| 9 Jul 2026 | Fail | Retatrutide Mokemei Zhengzhou Biotechnology MKM | lab name | View COA | |||
| 24 Jun 2026 | Fail | Retatrutide Mokemei Zhengzhou Biotechnology MKM | lab name | View COA | |||
| 23 Jun 2026 | Pass | GHK-Cu Mokemei Zhengzhou Biotechnology MKM | lab name | View COA | |||
| 12 Jun 2026 | Pass | GHK-Cu Mokemei Zhengzhou Biotechnology MKM | lab name | View COA | |||
| 1 Jun 2026 | Pass | Retatrutide Mokemei Zhengzhou Biotechnology MKM | lab name | View COA | |||
| 23 Apr 2026 | Pass | Retatrutide Mokemei Zhengzhou Biotechnology MKM | lab name | View COA | |||
| 23 Apr 2026 | Pass | Retatrutide Mokemei Zhengzhou Biotechnology MKM | lab name | View COA | |||
About Mokemei Zhengzhou Biotechnology MKM test results from Finnrick
Mokemei Zhengzhou Biotechnology MKM is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 14 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Mokemei Zhengzhou Biotechnology MKM peptides in this dataset are BPC-157 (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 14 recent tests.